Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2024-05-24 00:00:00 ET · period of report 2024-05-23 · accession 0001823239-24-000078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-24 | 2024-05-23 | MRVI | PRAHALAD MURALI | Dir | A - Grant | $10.78 | +20.6K | 65.5K | +46% | +$222.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-23 | A | A | 20,645 | $10.78 | 65,468 | D | — | — | (F1) Represents restricted stock units granted on May 23, 2024, which vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. |